- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/90 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 233/90
Total number of patents in this class: 445
10-year publication summary
|
19
|
29
|
41
|
24
|
33
|
28
|
19
|
27
|
23
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 456 |
14 |
| Koei Chemical Company, Limited | 58 |
12 |
| Bristol-myers Squibb Company | 4867 |
11 |
| Janssen Pharmaceutica N.V. | 3369 |
10 |
| Bayer AG | 3343 |
9 |
| FUJIFILM Corporation | 29543 |
9 |
| Nippon Soda Co., Ltd. | 894 |
8 |
| Boehringer Ingelheim International GmbH | 4642 |
7 |
| The General Hospital Corporation | 4759 |
7 |
| Arkema France | 4164 |
7 |
| Hoffmann-La Roche Inc. | 3461 |
6 |
| Bayer Cropscience AG | 2018 |
6 |
| Taisho Pharmaceutical Co., Ltd. | 866 |
6 |
| Takeda Pharmaceutical Company Limited | 2705 |
5 |
| Exelixis, Inc. | 400 |
5 |
| Hydro-Quebec | 651 |
5 |
| Imago Biosciences, Inc. | 39 |
5 |
| F. Hoffmann-La Roche AG | 7941 |
4 |
| AstraZeneca AB | 2908 |
4 |
| Merck Patent GmbH | 5824 |
4 |
| Other owners | 301 |